Varmam and milagu dhravagam internal for cervical spondylosis

An open clinical evaluation on Sagana Vadham (cervical spondylosis) with Varmam and Milagu dhravagam (internal)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027059

Enrollment

Registered

2020-08-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Milagu dhravagam: 2ml of milagu dhravagam will be given twice a day with 30ml of water after a meal for 21 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Complain about pain behind the neck (in the area of trapezius) Radiating pain to the upper limbs Numbness and weakness in arms, hands and fingers Muscle spasms in neck and shoulders Osteophyte formation Lhermitteâ??s sign and Spurlingâ??s test - Positive Shoulder abduction pain relief sign - Positive

Exclusion criteria

Exclusion criteria: Cervical rib Trauma Spina bifida Ankylosing spondylitis Malignancy Pregnancy and Lactation Cardiac disease Fracture Adhesive capsulitis Carpal tunnel syndrome

Design outcomes

Primary

Measure	Time frame
Pain reduction is evidenced by pain assessment scale (visual analogue scale), Neck disability index and Range of Motion Timepoint: 21 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment.Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Mohammed Mustafa

Government siddha medical college

musthafahod1122@gmail.com9840151147

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026